ChatGPT Shows Poor Performance in Answering Drug-Related Questions
By Lori Solomon HealthDay Reporter
TUESDAY, Dec. 12, 2023 -- ChatGPT provided no response or incomplete or wrong answers to nearly three-quarters of drug-related questions reviewed by pharmacists, according to a study presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting, held from Dec. 3 to 7 in Anaheim, California.
Sara Grossman, Pharm.D., from Long Island University in New York, and colleagues asked the publicly available, free version of ChatGPT 39 questions that had been posed to a drug information service. Two investigators compared ChatGPT responses to benchmark responses based on a literature search.
Of the 39 questions, the researchers reported that ChatGPT provided responses for 72 percent. Just over one-third of ChatGPT responses (36 percent) were accurate and complete and had no irrelevant information, whereas 64 percent had inaccurate or incomplete responses. One-third of the complex questions and 23 percent of the noncomplex questions were answered in a satisfactory manner.
"Health care professionals and patients should be cautious about using ChatGPT as an authoritative source for medication-related information," Grossman said in a statement. "Anyone who uses ChatGPT for medication-related information should verify the information using trusted sources."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-13 02:15
Read more
- Improvement Seen in Some Features of PCOS With Weight Loss Interventions
- Some IUDs May Raise The Odds for Breast Cancer, But Overall Risk Remains Low
- Quitting Smoking After Cancer Diagnosis Boosts Survival by Up to 26%
- Vaping Rates Hit Record Lows for U.S. High School Students
- Childbirth Can Bring Worrying Medical Bills, Even With Insurance
- FDA Approves Itovebi for Locally Advanced, Metastatic Breast Cancer
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions